Whitby, A.; Pabla, P.; Shastri, B.; Amugi, L.; Del Río-Álvarez, Á.; Kim, D.-H.; Royo, L.; Armengol, C.; Dandapani, M.
Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS). Cancers 2023, 15, 5182.
https://doi.org/10.3390/cancers15215182
AMA Style
Whitby A, Pabla P, Shastri B, Amugi L, Del Río-Álvarez Á, Kim D-H, Royo L, Armengol C, Dandapani M.
Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS). Cancers. 2023; 15(21):5182.
https://doi.org/10.3390/cancers15215182
Chicago/Turabian Style
Whitby, Alison, Pardeep Pabla, Bhoomi Shastri, Laudina Amugi, Álvaro Del Río-Álvarez, Dong-Hyun Kim, Laura Royo, Carolina Armengol, and Madhumita Dandapani.
2023. "Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS)" Cancers 15, no. 21: 5182.
https://doi.org/10.3390/cancers15215182
APA Style
Whitby, A., Pabla, P., Shastri, B., Amugi, L., Del Río-Álvarez, Á., Kim, D. -H., Royo, L., Armengol, C., & Dandapani, M.
(2023). Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS). Cancers, 15(21), 5182.
https://doi.org/10.3390/cancers15215182